FindTrial
Sign In

Effects of 1800 mg N-acetylcysteine in burnt patients with Acute Renal Failure

Effects of 1800 mg N-acetylcysteine in burnt patients with Acute Renal Failure

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100418003742N5
Enrollment
60
Registered
2020-01-12
Start date
2019-11-22
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Renal Failure in burninig patients. Acute kidney failure

Interventions

Intervention 1: Intervention group: Patients in case group will receive 1800 mg N-acetylcysteine in three divided doses. Intervention 2: Control group: Patients in the placebo group will be given in t

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Confirmation of the diagnosis of acute renal failure due to burns

Exclusion criteria

Exclusion criteria: Less than third degree burns and history of lasting kidney damage Having chronic kidney failure No consent to participate in the study

Design outcomes

Primary

MeasureTime frame
Urea changes. Timepoint: Date of admission and daily. Method of measurement: Blood urea check.;Creatinine changes. Timepoint: Date of admission and daily. Method of measurement: Blood creatinine check.;Duration of creatine fixation. Timepoint: The beginning and the daily. Method of measurement: File information.;Average 24-hour urine output. Timepoint: Daily. Method of measurement: Urine collection.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad abasgholizadeh

Tabriz University of Medical Sciences

dr.abasgholizadeh@gmail.com+98 913 340 4505

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026